Jie Xia

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Venues

Journal of chemical information and modeling

Molecules (Basel, Switzerland)

Cell death & disease

Journal of enzyme inhibition and medicinal chemistry

Chinese Academy of Medical Sciences and Peking Union Medical College Institute of Materia Medica

Peking University School of Pharmaceutical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Chinese Academy of Medical Sciences and Peking Union Medical College Institute of Materia Medica Oct 01 2018

China

Associate Investigator :: Department of New Drug Research and Development

Chinese Academy of Medical Sciences and Peking Union Medical College Institute of Materia Medica Sep 01 2015 - Aug 31 2018

China

Assistant Investigator :: Department of New Drug Research and Development

Education History

Peking University School of Pharmaceutical Sciences Sep 01 2010 - Jul 01 2015

China

PHD

Howard University College of Pharmacy Oct 06 2012 - Oct 07 2014

United States

PHD

Publications

Tao Shen, Jiale Guo, Zunsheng Han, Gao Zhang, Qingxin Liu, Xinxin Si, Dongmei Wang, Song Wu, Jie Xia
AutoMolDesigner for Antibiotic Discovery: An AI-Based Open-Source Software for Automated Design of Small-Molecule Antibiotics. Journal of chemical information and modeling (2024)
Tao Shen, Jiale Guo, Zunsheng Han, Gao Zhang, Qingxin Liu, Xinxin Si, Dongmei Wang, Song Wu, Jie Xia
AutoMolDesigner for Antibiotic Discovery: An AI-Based Open-Source Software for Automated Design of Small-Molecule Antibiotics. Journal of chemical information and modeling 64 (3) (2024)
Tao Shen, Jiale Guo, Zunsheng Han, Gao Zhang, Qingxin Liu, Xinxin Si, Dongmei Wang, Song Wu, Jie Xia
AutoMolDesigner for Antibiotic Discovery: An AI-Based Open-Source Software for Automated Design of Small-Molecule Antibiotics. Journal of chemical information and modeling 64 (3) (2024)
Xinxin Si, Chenliang Qian, Nian-Zhuang Qiu, Yaling Wang, Mingli Yao, Hao Wang, Xuehui Zhang, Jie Xia
Discovery of a novel DYRK1A inhibitor with neuroprotective activity by virtual screening and in vitro biological evaluation. Molecular diversity (2024)
Tao Shen, Jiale Guo, Zunsheng Han, Gao Zhang, Qingxin Liu, Xinxin Si, Dongmei Wang, Song Wu, Jie Xia
AutoMolDesigner for Antibiotic Discovery: An AI-Based Open-Source Software for Automated Design of Small-Molecule Antibiotics. Journal of chemical information and modeling 64 (3) (2024)
Tao Shen, Jiale Guo, Zunsheng Han, Gao Zhang, Qingxin Liu, Xinxin Si, Dongmei Wang, Song Wu, Jie Xia
AutoMolDesigner for Antibiotic Discovery: An AI-Based Open-Source Software for Automated Design of Small-Molecule Antibiotics. Journal of chemical information and modeling 64 (3) (2024)
Zihao Zhu, Cantong Chen, Jie Zhang, Fangfang Lai, Jing Feng, Guangxu Wu, Jie Xia, Wen-Xuan Zhang, Zunsheng Han, Chi Zhang, Qingyun Yang, Yuchen Wang, Bo Liu, Tianlei Li, Song Wu
Exploration and Biological Evaluation of 1,3-Diamino-7 H -pyrrol[3,2- f ]quinazoline Derivatives as Dihydrofolate Reductase Inhibitors. Journal of medicinal chemistry (2023)
Junhui Yu, Kui Yang, Jianbao Zheng, Pengwei Zhao, Jie Xia, Xuejun Sun, Wei Zhao
Correction: Activation of FXR and inhibition of EZH2 synergistically inhibit colorectal cancer through cooperatively accelerating FXR nuclear location and upregulating CDX2 expression. Cell death & disease 14 (2) (2023)
Junhui Yu, Kui Yang, Jianbao Zheng, Pengwei Zhao, Jie Xia, Xuejun Sun, Wei Zhao
Correction: Activation of FXR and inhibition of EZH2 synergistically inhibit colorectal cancer through cooperatively accelerating FXR nuclear location and upregulating CDX2 expression. Cell death & disease 14 (2) (2023)
Na Li, Lin Yin, Xi Chen, Jiamin Shang, Meidai Liang, Li Gao, Guifen Qiang, Jie Xia, Guanhua Du, Xiuying Yang
Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor. Molecules (Basel, Switzerland) 27 (24) (2022)
Na Li, Lin Yin, Xi Chen, Jiamin Shang, Meidai Liang, Li Gao, Guifen Qiang, Jie Xia, Guanhua Du, Xiuying Yang
Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor. Molecules (Basel, Switzerland) 27 (24) (2022)
Wenjie Xue, Yaling Wang, Xu Lian, Xueyao Li, Jing Pang, Johannes Kirchmair, Kebin Wu, Zunsheng Han, Xuefu You, Hongmin Zhang, Jie Xia, Song Wu
Discovery of N -quinazolinone-4-hydroxy-2-quinolone-3-carboxamides as DNA gyrase B-targeted antibacterial agents. Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Junhui Yu, Kui Yang, Jianbao Zheng, Pengwei Zhao, Jie Xia, Xuejun Sun, Wei Zhao
Activation of FXR and inhibition of EZH2 synergistically inhibit colorectal cancer through cooperatively accelerating FXR nuclear location and upregulating CDX2 expression. Cell death & disease 13 (4) (2022)
Na Li, Lin Yin, Xi Chen, Jiamin Shang, Meidai Liang, Li Gao, Guifen Qiang, Jie Xia, Guanhua Du, Xiuying Yang
Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor. Molecules (Basel, Switzerland) 27 (24) (2022)
Na Li, Lin Yin, Xi Chen, Jiamin Shang, Meidai Liang, Li Gao, Guifen Qiang, Jie Xia, Guanhua Du, Xiuying Yang
Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor. Molecules (Basel, Switzerland) 27 (24) (2022)
Na Li, Lin Yin, Xi Chen, Jiamin Shang, Meidai Liang, Li Gao, Guifen Qiang, Jie Xia, Guanhua Du, Xiuying Yang
Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor. Molecules (Basel, Switzerland) 27 (24) (2022)
Tong Qin, Zihao Zhu, Xiang Simon Wang, Jie Xia, Song Wu
Computational representations of protein-ligand interfaces for structure-based virtual screening. Expert opinion on drug discovery 16 (10) (2021)
Jie Xia, Zhenyi Wang, Yi Huan, Wenjie Xue, Xing Wang, Yuxi Wang, Zhen-Ming Liu, Jui-Hua Hsieh, Liangren Zhang, Song Wu, Zhufang Shen, Hongmin Zhang, Xiang Simon Wang
Pose Filter-Based Ensemble Learning Enables Discovery of Orally Active, Nonsteroidal Farnesoid X Receptor Agonists. Journal of chemical information and modeling 60 (3) (2020)
Jie Xia, Huabin Hu, Wenjie Xue, Xiang Simon Wang, Song Wu
The discovery of novel HDAC3 inhibitors via virtual screening and in vitro bioassay. Journal of enzyme inhibition and medicinal chemistry 33 (1) (2018)
Jie Xia, Terry-Elinor Reid, Song Wu, Liangren Zhang, Xiang Simon Wang
Maximal Unbiased Benchmarking Data Sets for Human Chemokine Receptors and Comparative Analysis. Journal of chemical information and modeling 58 (5) (2018)
Jie Xia, Jui-Hua Hsieh, Huabin Hu, Song Wu, Xiang Simon Wang
The Development of Target-Specific Pose Filter Ensembles To Boost Ligand Enrichment for Structure-Based Virtual Screening. Journal of chemical information and modeling 57 (6) (2017)

Jie Xia.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jie Xia